Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,752,753
Closed -$121M 46
2016
Q3
$121M Hold
3,752,753
5.24% 3
2016
Q2
$125M Sell
3,752,753
-959,562
-20% -$30.6M 5.77% 2
2016
Q1
$132M Sell
4,712,315
-100,130
-2% -$2.86M 6.35% 2
2015
Q4
$147M Sell
4,812,445
-97,706
-2% -$3.07M 6.87% 2
2015
Q3
$146M Buy
+4,910,151
New +$157M 6.88% 2
2014
Q1
Sell
-3,880,965
Closed -$113M 55
2013
Q4
$113M Hold
3,880,965
5.88% 1
2013
Q3
$106M Sell
3,880,965
-283,210
-7% -$7.71M 7.8% 1
2013
Q2
$111M Buy
+4,164,175
New +$115M 6.71% 1

Other funds holding PFE

Alliance Trust's PFE Position: Q4 2016 in Review

Alliance Trust sold out of Pfizer (PFE) in Q4 2016, closing a stake of 3,752,753 shares — an estimated $121M sold.

Alliance Trust first reported a position in PFE in Q2 2013 and held it in 8 quarters. The position peaked at $147M in Q4 2015. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • Alliance Trust reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
  • Alliance Trust sold 3,752,753 Pfizer shares in Q4 2016, an estimated $121M.
  • Alliance Trust first reported a position in Pfizer in Q2 2013 and held it in 8 quarters.
  • Alliance Trust's Pfizer position peaked at $147M in Q4 2015.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Alliance Trust's 13F filing for Q4 2016, filed 7 Feb 2017.